Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is one of the most aggressive lung cancers. Treatment of SCLC has remained unchanged during the past decades. Preclinical studies have revealed ASCL1 as a transcription regulator in the neuroendocrine (NE) differentiation and carcinogenesis of SCLC. However,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Wei, Jiacong, Liu, Li, Guo, Yiying, Zhang, Jinyao, Wang, Xin, Dong, Jiyan, Xing, Puyuan, Ying, Jianming, Yang, Lin, Li, Junling
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779202/
https://ncbi.nlm.nih.gov/pubmed/33191657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13705
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars